Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Single Nucleotide Polymorphisms in Seps1 and Sepp1 on Expression in the Protein Level in Metabolic Syndrome in Subjects With Cardiovascular Disease Publisher Pubmed



Gharipour M1 ; Ouguerram K2 ; Nazih EH3 ; Salehi M4 ; Behmanesh M5 ; Razavi R6 ; Gharipour A7 ; Diantkhah M1 ; Sadeghi M8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. UMR PHAN, INRA & Universite de Nantes, IMAD, CRNH-Ouest, Nantes, France
  3. 3. IUML—Institut Universitaire Mer et Littoral—FR3473 CNRS, MMS-EA2160, Nantes, France
  4. 4. Department of Genetics and Molecular Biology Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  6. 6. Department of Management and Information Systems, Kent State University, Kent, OH, United States
  7. 7. Department of Accounting, Finance and Economics, Griffith University, Gold Coast Campus, Australia
  8. 8. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Molecular Biology Reports Published:2019


Abstract

Metabolic syndrome (MetS) results from the interaction between environmental and genetic factors. Several previous studies considered the role of selenium in developing MetS. Two selenoproteins, selenoprotein S (SelS), and the Selenoprotein P (SePP) play an important role in antioxidative defense and therefore susceptibility to MetS. The involvement of SNPs in SEPP1 and SEPS1 have not been studied in MetS subjects. This study aims to investigate the association between the risk of MetS and four polymorphisms SEPS1 (rs28665122, rs4965373), SEPP1 (rs7579, rs3877899) in an Iranian population. The sample of this case–control study consisted of 132 Iranian patients with cardiovascular disease (71 MetS and 65 non-MetS subjects) from December 2015 to March 2016. Demographic data, medical history, and para-clinical were measured, and Taqman probes were used for allelic discrimination. The level of the SelS and the SePP were measured by the ELIZA method. No significant differences were found in the genotype frequencies of SEPS1 (rs4965373, rs28665122), SEPP1 (rs7579, rs3877899) in patients with MetS and the non-MetS group. The mean of SelS in MetS subjects with SEPS1 (rs4965373) GG genotype is significantly lower than the non-MetS group (4496.99 ± 3688.5 vs. 6148.6 ± 1127.0, P = 0.009). The mean of SePP in MetS subjects with SEPP1 (rs3877899) GG genotype is significantly lower than the non-MetS group (40.73 ± 8.44 vs.83.91 ± 21.33, P = 0.002). The mean of SePP in MetS subjects with SEPP1 (rs7579) GG genotype is lower than the non-MetS group (55.52 ± 16.7 vs. 109.48 ± 29.78, P = 0.01). In summary, the results of this study does not indicate significant differences in the SEPP1 (rs7579, rs3877899) and SEPS1 (rs4965373, rs28665122) genotypes between MetS and non-MetS subjects. However, the results show that the mean of expression of SelS and SePP decreased in the subjects with SEPP1 (rs7579) GG and SEPP1 (rs3877899) GG. © 2019, Springer Nature B.V.
Experts (# of related papers)
Other Related Docs
13. Obesity and Metabolic Syndrome Among a Representative Sample of Iranian Adolescents, Southeast Asian Journal of Tropical Medicine and Public Health (2012)
34. Precision Medicine and Metabolic Syndrome, ARYA Atherosclerosis (2022)
45. Study of the Correlation of Serum Selenium Level With Behcet's Disease, International Journal of Rheumatic Diseases (2011)